In Castello Cros et al.’s study, it has been found that Cav-1 expression is lower in affected tissues of SSc patients compared with normal tissues, and restoration of Cav-1 expression in vitro experiments alleviates skin fibrosis levels. The gene discussed is CAV1; the disease is systemic sclerosis.